A provider briefing on Augmentin XR supply disruptions in 2026. Covers availability, prescribing implications, alternatives, and patient access tools.
If your patients have been reporting difficulty filling Augmentin XR prescriptions, you're hearing a signal worth paying attention to. While Augmentin XR (Amoxicillin/Clavulanate Potassium Extended-Release 1000mg/62.5mg) is no longer listed as an active shortage on the FDA's drug shortage database, real-world availability remains inconsistent. This briefing covers the current landscape, clinical implications for your practice, and tools you can use to help patients access their medications.
Augmentin XR's supply challenges have been evolving over several years:
The supply situation creates several practical considerations for prescribers:
Consider directing patients to check stock at their pharmacy before leaving the office. A tool like Medfinder for Providers can help you or your staff verify real-time availability at pharmacies near your patient. This avoids the frustrating scenario where a patient drives to the pharmacy only to be told the medication is unavailable.
When writing prescriptions for Augmentin XR, prescribe as Amoxicillin/Clavulanate Potassium ER 1000mg/62.5mg to give pharmacists maximum flexibility in sourcing from available manufacturers. DAW (Dispense as Written) restrictions on brand-name Augmentin XR will further limit access since the brand is discontinued in many markets.
Given supply uncertainty, consider discussing a backup plan with patients at the point of prescribing. If they can't fill the Augmentin XR prescription within 24-48 hours, they should know to call your office for an alternative rather than going without treatment.
Based on supply chain data and pharmacy reports in early 2026:
Cost remains a significant access barrier for some patients, particularly those without insurance or with high-deductible plans:
For patients facing cost barriers, direct them to our patient-facing savings guide: How to Save Money on Augmentin XR. For provider-specific cost management strategies, see our provider's guide to helping patients save on Augmentin XR.
When Augmentin XR is unavailable, the following alternatives may be appropriate depending on the clinical scenario:
For a patient-facing comparison of these alternatives, direct patients to: Alternatives to Augmentin XR.
Several tools can help streamline medication access for your patients:
The domestic manufacturing approval granted to USAntibiotics in 2025 represents a structural improvement in the antibiotic supply chain. As domestic production ramps up, the recurring pattern of seasonal shortages for amoxicillin-based antibiotics should improve — though the timeline for full stabilization remains uncertain.
In the meantime, the most effective strategy is proactive planning: verify availability before prescribing, prescribe generically, maintain a list of appropriate alternatives for your patient population, and leverage tools like Medfinder to stay ahead of supply disruptions.
Augmentin XR supply challenges are a manageable problem when approached systematically. The key for providers is awareness — knowing that the ER formulation is harder to find than standard Augmentin, preparing patients with realistic expectations, and having clear protocols for alternative prescribing when needed.
For additional clinical context, our companion articles cover helping patients find Augmentin XR in stock, Augmentin XR uses and dosage, and drug interactions to be aware of.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
